Clinical trials: Resistance Exercise
Insulin, Exercise
Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
To determine if physical activity engagement alters the dose-response profile and safety of administration of insulin into the intranasal mucosa.
- Trial name
- NCT04292535
- Testing
- 20 IU NovoLog Insulin aspart into the intranasal mucosa, 40 IU NovoLog Insulin aspart into the intranasal mucosa, 60 IU NovoLog Insulin aspart into the intranasal mucosa
- Where
- United States
- Volunteers
- 116 people, healthy volunteers welcome
- Sponsor
- Michigan State University